Ciphergen Reports Biomarkers of Alzheimer's Disease
July 18 2006 - 10:00AM
PR Newswire (US)
Results Presented at the 10th International Conference of
Alzheimer's Disease, July 15-20, 2006 in Madrid, Spain FREMONT,
Calif., July 18 /PRNewswire-FirstCall/ -- Ciphergen Biosystems,
Inc. (NASDAQ:CIPH) announced today results of a multi-site study
aimed at discovering and validating biomarkers for Alzheimer's
disease. For biomarker discovery, cerebrospinal fluid (CSF) samples
were analyzed from 65 Alzheimer's disease patients and 44 controls.
Thirty peaks were identified with p
Ciphergen Biosystems (NASDAQ:CIPH)
Historical Stock Chart
From May 2024 to Jun 2024
Ciphergen Biosystems (NASDAQ:CIPH)
Historical Stock Chart
From Jun 2023 to Jun 2024
